F2-isoprostanes and Metabolite, and Breast Cancer Risk.
Dai
Qi
Q
Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, School of Medicine, Vanderbilt University, Nashville, TN.
Zhu
Xiangzhu
X